BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11001891)

  • 1. Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience.
    Tallman MS; Neuberg D; Bennett JM; Francois CJ; Paietta E; Wiernik PH; Dewald G; Cassileth PA; Oken MM; Rowe JM
    Blood; 2000 Oct; 96(7):2405-11. PubMed ID: 11001891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The translocation t(1;22)(p13;q13) is a nonrandom marker specifically associated with acute megakaryocytic leukemia in young children.
    Lion T; Haas OA; Harbott J; Bannier E; Ritterbach J; Jankovic M; Fink FM; Stojimirovic A; Herrmann J; Riehm HJ
    Blood; 1992 Jun; 79(12):3325-30. PubMed ID: 1596573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute megakaryoblastic leukemia: experience of GIMEMA trials.
    Pagano L; Pulsoni A; Vignetti M; Mele L; Fianchi L; Petti MC; Mirto S; Falcucci P; Fazi P; Broccia G; Specchia G; Di Raimondo F; Pacilli L; Leoni P; Ladogana S; Gallo E; Venditti A; Avanzi G; Camera A; Liso V; Leone G; Mandelli F;
    Leukemia; 2002 Sep; 16(9):1622-6. PubMed ID: 12200673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloblastic leukemia with minimal myeloid differentiation (FAB AML-M0): a study of eleven cases.
    Sempere A; Jarque I; Guinot M; Palau J; García R; Sanz GF; Gomis F; Pérez-Sirvent ML; Senent L; Sanz MA
    Leuk Lymphoma; 1993 Dec; 12(1-2):103-8. PubMed ID: 8161925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group.
    Bradstock K; Matthews J; Benson E; Page F; Bishop J
    Blood; 1994 Aug; 84(4):1220-5. PubMed ID: 8049437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
    Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
    Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homoharringtonine combined with cytarabine to treat chronic myelogenous leukemia in myeloid blast crisis and its impact on bone marrow CD34+CD7+ cells.
    Li Y; Deng Z; Zho J; Ding B; Shi Y; Li Y
    Acta Haematol; 2014; 132(2):172-6. PubMed ID: 24603361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases.
    Ribeiro RC; Oliveira MS; Fairclough D; Hurwitz C; Mirro J; Behm FG; Head D; Silva ML; Raimondi SC; Crist WM
    Leuk Lymphoma; 1993 Jul; 10(4-5):299-306. PubMed ID: 8220128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factors.
    Stasi R; Venditti A; Del Poeta G; Aronica G; Dentamaro T; Cecconi M; Stipa E; Scimò MT; Masi M; Amadori S
    Cancer; 1996 Jun; 77(12):2476-88. PubMed ID: 8640696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology Group.
    Cassileth PA; Andersen JW; Bennett JM; Harrington DP; Hines JD; Lazarus HM; Mazza JJ; McGlave PP; O'Connell MJ; Paietta E
    Leukemia; 1992; 6 Suppl 2():116-9. PubMed ID: 1578910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0).
    Stasi R; Del Poeta G; Venditti A; Masi M; Stipa E; Dentamaro T; Cox C; Dallapiccola B; Papa G
    Blood; 1994 Mar; 83(6):1619-25. PubMed ID: 8123853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of acute megakaryoblastic leukaemia (FAB M7), a rare type of acute myeloid leukemia (AML), in a teenager.
    Olatunji PO; Ojo OT; Bello FO; Bakare BY; Olatunji AO
    Malawi Med J; 2018 Dec; 30(4):298-301. PubMed ID: 31798811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.
    Suzuki R; Murata M; Kami M; Ohtake S; Asou N; Kodera Y; Tomonaga M; Masaki Y; Kusumoto S; Takeuchi J; Matsuda S; Hirai H; Yorimitsu mS; Hamajima N; Seto M; Shimoyama M; Ohno R; Morishima Y; Nakamura S
    Int J Hematol; 2003 Jun; 77(5):482-9. PubMed ID: 12841387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Survival, clinical and laboratory characteristics of de novo and secondary megakaryoblastic leukemia].
    Crespo E; López-Karpovitch X; Abraham-Simón J; Lome-Maldonado C; Piedras J
    Rev Invest Clin; 2003; 55(5):494-501. PubMed ID: 14968469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia.
    Chang H; Salma F; Yi QL; Patterson B; Brien B; Minden MD
    Leuk Res; 2004 Jan; 28(1):43-8. PubMed ID: 14630079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult acute leukemia.
    Cripe LD
    Curr Probl Cancer; 1997; 21(1):1-64. PubMed ID: 9058027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup.
    Delaunay J; Vey N; Leblanc T; Fenaux P; Rigal-Huguet F; Witz F; Lamy T; Auvrignon A; Blaise D; Pigneux A; Mugneret F; Bastard C; Dastugue N; Van den Akker J; Fière D; Reiffers J; Castaigne S; Leverger G; Harousseau JL; Dombret H; ; ; ; ;
    Blood; 2003 Jul; 102(2):462-9. PubMed ID: 12649129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute megakaryoblastic leukemia: establishment of a new cell line (MKPL-1) in vitro and in vivo.
    Takeuchi S; Sugito S; Uemura Y; Miyagi T; Kubonishi I; Taguchi H; Enzan H; Ohtsuki Y; Miyoshi I
    Leukemia; 1992 Jun; 6(6):588-94. PubMed ID: 1602796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS.
    Pigneux A; Harousseau JL; Witz F; Sauvezie M; Bene MC; Luquet I; Hunault-Berger M; Recher C; Lioure B; Himberlin C; Escoffre-Barbe M; Berthou C; Lissandre S; Fegueux N; Cahn JY; Jourdan E; Dreyfus F; Reiffers J; Milpied N; Ifrah N
    J Clin Oncol; 2010 Jun; 28(18):3028-34. PubMed ID: 20479424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients.
    Schoch C; Haferlach T; Haase D; Fonatsch C; Löffler H; Schlegelberger B; Staib P; Sauerland MC; Heinecke A; Büchner T; Hiddemann W;
    Br J Haematol; 2001 Jan; 112(1):118-26. PubMed ID: 11167792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.